Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

New tool to defeat brain cancer

Glioblastoma, the virulent form of brain cancer that killed Ted Kennedy in the span of a year, has a helper. A protein called NF-kB is a tonic for the malignant cells, energizing them to proliferate at high speed. After discovering this link, scientists at the Salk Institute also discovered a protein and peptide that hamper the brain’s production of NF-kB and significantly increased the lifespan of affected lab mice in experiments. The protein and peptide can be created by the brain itself through genetic manipulation or could be introduced as a drug.

TRENDPOST: The trend in treating cancer is to enlist nature’s own entities instead of invasive surgeries or radiation as cures. Empty viruses stocked with medicine can bond to cancer cells and deliver their payload; the body’s own counter-chemicals can be directed to the rogue cells. For the first time, scientists are talking with confidence about curing common forms of cancer by 2030.

Comments are closed.